Prevalence of Musculoskeletal Disorders of Upper Limb in Type 1 Diabetes Patients

• Conditions: Type 1 Diabetes
• Interventions: Other: Data collection

• Registration Number: NCT05164562
• Lead Sponsor: Université de Reims Champagne-Ardenne

Brief Summary

Osteopenia and osteoporosis, particularly related to insulinopenia, are common in type 1 diabetes and increase the risk of fractures. Musculoskeletal disorders of the upper limb are a common complication of type 1 diabetes. However, there is no official recommendation for screening for musculoskeletal disorders in France.

Detailed Description

The aim of the study is to describe prevalence of musculoskeletal disorders of upper limb in type 1 diabetes patients.

Study Timeline

• Study First Submitted: 2021-12-07
• Study First Submitted QC: 2021-12-07
• Study First Posted: 2021-12-20
• Study Start: 2022-01-07
• Status Verified: 2022-03
• Last Update Submitted: 2022-03-29
• Last Update Posted: 2022-04-07
• Primary Completion: 2022-07-01
• Study Completion: 2023-01-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• male or female
• aged of 18 and more
• with type 1 diabetes
• agreeing to participate in the study

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
type 1 diabetes	Data collection	"type 1 diabetes" group: patients with type 1 diabetes

Primary Outcome Measures

Name	Time	Method
musculoskeletal disorders of upper limb	Day 0	musculoskeletal disorders of upper limb evaluated using Quick Dash (Quick Disabilities of Arm, Shoulder and Hand).; Quick Dash is a 11 items questionnaire that measures an individual's ability to complete tasks, absorb forces, and severity of symptoms. The QuickDASH tool uses a 5-point Likert scale from which the patient can select an appropriate number corresponding to his/her severity/function level. The score ranges from 0 (no disability) to 100 (most severe disability), a higher score indicates a greater level of disability and severity, whereas, lower score indicates a lower level of disability.

Trial Locations

Locations (1)

Centre Hospitalier Universitaire de Reims; 🇫🇷 Reims, Grand-Est, France